Profil
Michael Steiner has a current job as a Member-Supervisory Board at Bitop AG.
Aktive Positionen von Michael Steiner
Unternehmen | Position | Beginn |
---|---|---|
Bitop AG
Bitop AG Household/Personal CareConsumer Non-Durables Part of UWH Beteiligungsgesellschaft mbH, Bitop AG is a German company that specializes in the production and application of ectoin® and other extremolytes for pharmaceutical, cosmetics, life science, and animal care industries. The company is based in Witten, Germany. The company offers patent-protected OTC medical devices, highly effective cosmetic ingredients, and unique animal health and care products. Bitop's products include medicine for coughing and colding, allergic diseases of the eye, and health and well-being. The company also offers cosmetic active ingredients and life science solutions for the stabilization of biomolecules. Bitop's recent in vitro study on lung cells with SARS-CoV-2 shows virus-blocking efficacy of Bitop ectoin®. Bitop was founded in 1993 by Thomas Schwarz, and Michael Braig has been the CEO of the company since 2019. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Bitop AG
Bitop AG Household/Personal CareConsumer Non-Durables Part of UWH Beteiligungsgesellschaft mbH, Bitop AG is a German company that specializes in the production and application of ectoin® and other extremolytes for pharmaceutical, cosmetics, life science, and animal care industries. The company is based in Witten, Germany. The company offers patent-protected OTC medical devices, highly effective cosmetic ingredients, and unique animal health and care products. Bitop's products include medicine for coughing and colding, allergic diseases of the eye, and health and well-being. The company also offers cosmetic active ingredients and life science solutions for the stabilization of biomolecules. Bitop's recent in vitro study on lung cells with SARS-CoV-2 shows virus-blocking efficacy of Bitop ectoin®. Bitop was founded in 1993 by Thomas Schwarz, and Michael Braig has been the CEO of the company since 2019. | Consumer Non-Durables |